The Johns Hopkins Pediatric Bone Marrow Transplant (BMT) Program is a leader in the use of haploidentical donors and the delivery of novel immune therapies for difficult-to-treat cancers, placing the BMT program at the cutting edge of cancer treatment.
Donations in honor of James will benefit physician- scientists within the Division of Pediatric Oncology in the Johns Hopkins Kimmel Cancer Center with research initiatives in the following areas:
•Improving negative side-effects and complications associated with graft-versus-host disease (GVHD)
•Overcoming traditional barriers associated with blood stem cell donor availability and optimizing the selection of the best possible available donor.
•Developing strategies for post-transplant immunotherapy to prevent
•Novel BMT approaches to ultra-high-risk solid tumor cancers.